Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 789, Issue -, Pages 109-118Publisher
ELSEVIER
DOI: 10.1016/j.ejphar.2016.07.027
Keywords
Berberine; Osteoarthritis; Chondrocyte; Sodium nitroprusside; Proliferation; Wnt/beta-catenin
Categories
Ask authors/readers for more resources
Berberine chloride (BBR) is an isoquinoline derivative alkaloid isolated from medicinal herbs, including Coptis chinensis and Berberis aristate. This compound plays significant roles in the treatment of osteoarthritis (OA). The purpose of this study was to investigate the effects of BBR on the proliferation of sodium nitroprusside (SNP)-stimulated chondrocytes in vitro, the articular cartilage in a rat OA model, as well as to discuss the molecular mechanisms underlying these effects. In vitro, we demonstrated that BBR led to cell proliferation, increased the cell population in S-phase and decreased that in G0/G1-phase; moreover, the F-actin remodeling in SNP-stimulated chondrocytes were prevented. In addition, BBR markedly up-regulated P-catenin, c-Myc, and cyclin Dl expression of genes and proteins, and down regulated glycogen synthase kinase-3 beta (GSK-3 beta) and matrix metalloproteinase-7 (MMP-7) expression. Notably, inhibition of the Wnt/beta-catenin pathway by XAV939 partially blocked these effects. The in vivo results suggested that BBR promoted P-catenin protein level and enhanced proliferating cell nuclear antigen (PCNA) expression in osteoarthritic rat cartilage. In conclusion, these findings indicate that BBR promotes SNP-stimulated chondrocyte proliferation by promoting G1/S phase transition and synthesis of PCNA in cartilage through activation of Wnt/beta-catenin signaling pathway. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available